Madison Corona, ATC, LAT in Lawrence, KS - Preventive Medicine

Madison Corona, ATC, LAT is a Preventive Medicine - Sports Medicine physician based in Lawrence, Kansas. Madison Corona is licensed to practice in Kansas (license number 24-01493) and her current practice location is 1651 Naismith Dr, Lawrence, Kansas. She can be reached at her office (for appointments etc.) via phone at (785) 393-3342.

NPI number for Madison Corona is 1568185007 and her current mailing address is 1651 Naismith Dr, Lawrence, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1568185007.

Contact Information

	Madison Corona, ATC, LAT
	1651 Naismith Dr, Lawrence, KS 66045-4069
	(785) 393-3342
	Not Available

Physician's Profile

Full Name	Madison Corona
Gender	Female
Speciality	Preventive Medicine - Sports Medicine
Location	1651 Naismith Dr, Lawrence, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1568185007
Provider Enumeration Date: 09/20/2022
Last Update Date: 09/20/2022

Medical Identifiers

Medical identifiers for Madison Corona such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568185007	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083S0010X	Preventive Medicine - Sports Medicine	24-01493 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Madison Corona is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Madison Corona, ATC, LAT 1651 Naismith Dr, Lawrence, KS 66045-4069 Ph: (785) 393-3342	Madison Corona, ATC, LAT 1651 Naismith Dr, Lawrence, KS 66045-4069 Ph: (785) 393-3342

News Archive

Phase IIb/III clinical trial results of CINQUIL for pediatric EoE announced

Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay

Fujirebio Diagnostics, Inc., a consolidated subsidiary of H.U. Group Holdings, Inc, announced today the initiation of clinical testing needed for the submission of its new SARS-CoV-2 Antigen assay for EUA (Emergency Use Authorization) from the U.S. Food and Drug Administration.

Weightlifting program does not increase risk of lymphedema in breast cancer survivors

A slowly progressive weight lifting program for breast cancer survivors did not increase their risk of lymphedema (arm swelling and discomfort), according to a study that will appear in the December 22/29 issue of JAMA. The study is being released early online to coincide with its presentation at the San Antonio Breast Cancer Symposium.

Significant correlation between vitamin D and excessive daytime sleepiness

A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.

Madison Corona, ATC, LAT - Preventive Medicine in Lawrence, KS